KAS
IRMD icon

Kestra Advisory Services’s iRadimed IRMD Stock Holding History

Kestra Advisory Services’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-215
Closed -$20.9K – 3751
2025
Q4 		$20.9K Buy
+215
New +$18.4K ﹤0.01% 4492

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kestra Advisory Services's IRMD Position: Q1 2026 in Review

Kestra Advisory Services sold out of iRadimed (IRMD) in Q1 2026, closing a stake of 215 shares — an estimated $20.9K sold.

Kestra Advisory Services first reported a position in IRMD in Q4 2025 and held it in 1 quarter. The position peaked at $20.9K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Kestra Advisory Services reported no remaining iRadimed position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 215 iRadimed shares in Q1 2026, an estimated $20.9K.
  • Kestra Advisory Services first reported a position in iRadimed in Q4 2025 and held it in 1 quarter.
  • Kestra Advisory Services's iRadimed position peaked at $20.9K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.